Reports for ALLERGAN INC

Company Name

ALLERGAN INC

Totals

Shortage reports

29

Actual shortage: 9 (31%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 20 (69%)

Discontinuation Reports

2

To be discontinued: 1 (50%)
Discontinued: 1 (50%)
Reversed: 0 (0%)

Late reports

6 (19%)

Overdue reports

4 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Last updated Reports
RAPAFLO 4MG CAPSULE Resolved 2018-07-20 2018-09-25 56121
RESTASIS MULTIDOSE 0.05% EMULSION Actual shortage 2019-02-01 2019-02-01 74356
TAZORAC 0.05% GEL Actual shortage 2018-11-01 2018-11-01 65978
TAZORAC 0.1% GEL Resolved 2018-11-02 2018-12-01 66125
TAZORAC 0.05% CREAM Resolved 2018-11-02 2018-12-01 66116
VIIBRYD 10MG TABLET Resolved 2019-01-15 2019-02-28 72344
VIIBRYD 10MG TABLET Actual shortage 2019-02-28 2019-03-19 77159
VIIBRYD 20MG TABLET Actual shortage 2019-01-15 2019-03-22 72342
ZYMAR 0.3% SOLUTION Resolved 2017-08-03 2017-10-13 18241

Showing 21 to 29 of 29

Discontinuation reports
Brand name Strength Dosage Status Date Created Last updated Reports
ALOCRIL 2% LIQUID To be discontinued 2018-11-28 2018-11-28 67803
BETAGAN OPH SOLN 0.25% 0.25% LIQUID Discontinued 2017-08-04 2017-08-04 18275